financetom
Business
financetom
/
Business
/
Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health
Jun 12, 2024 6:49 AM

09:26 AM EDT, 06/12/2024 (MT Newswires) -- Zimmer Biomet Holdings ( ZBH ) and RevelAi Health said Wednesday they have entered into an agreement to market RevelAi Health's products and services.

They said that under the multiyear co-marketing deal, Zimmer Biomet ( ZBH ) will commercialize the patient care-management platform, care team dashboard for providers, and any future products or services of RevelAi, a software as a service health technology company. Financial details weren't provided.

Price: 111.00, Change: +1.77, Percent Change: +1.62

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nebius Rewrites Expectations — Next Stop $200?
Nebius Rewrites Expectations — Next Stop $200?
Mar 16, 2026
Nebius Group ( NBIS ) may have just had its long‑term story rewritten — and two fresh $200 price targets suggest the market is still catching up. NBIS stock is moving. See the chart and price action here.  Street Chases The Tape DA Davidson and BWS Financial both lifted their Nebius ( NBIS ) targets to $200 on Monday, up...
Swarmer Prices $15 Million Initial Public Offering
Swarmer Prices $15 Million Initial Public Offering
Mar 16, 2026
05:58 PM EDT, 03/16/2026 (MT Newswires) -- Swarmer said late Monday it has priced its initial public offering of 3 million shares at $5 per share. Swarmer said it has granted its underwriter, Lucid Capital Markets, a 30-day option to purchase up to an additional 450,000 shares. The drone autonomy software company said it plans to use the net proceeds...
Pono Capital Four, Inc. Announces Closing of $120,000,000 Initial Public Offering
Pono Capital Four, Inc. Announces Closing of $120,000,000 Initial Public Offering
Mar 16, 2026
GRAND CAYMAN, Cayman Islands, March 16, 2026 (GLOBE NEWSWIRE) -- Pono Capital Four, Inc. ( PONOU ) (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 12,000,000 units, at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the...
AptarGroup's Nasal Delivery System Supports Phase II Study of Spontan
AptarGroup's Nasal Delivery System Supports Phase II Study of Spontan
Mar 16, 2026
05:57 PM EDT, 03/16/2026 (MT Newswires) -- AptarGroup ( ATR ) said late Monday that its proprietary intranasal delivery system is being used in LTR Pharma's Phase II trial of Spontan, an investigational nasal spray for erectile dysfunction. The Phase II trial, now enrolling its first patients, is assessing the safety, tolerability, and pharmacokinetics of the rapid-acting nasal spray, with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved